In DDW and ELRIG UK's Drug Discovery 2021 supplement, CEO and Founder of Egality Health, Annette Crosse, offers insight into the importance of diversity in clinical trials and of overcoming limitations in healthcare research to re-imagine a system which provides safe, effective and innovative therapies for the entire population.  Annette Crosse describes Egality Health as a start-up […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!